DEBT (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Debt Disclosure [Abstract] |
|
| Schedule of Components of Debt |
The components of the Company’s debt are as follows: | | | | | | | | | | | | | | | | | | | | | | Effective Interest Rate | Contractual Maturity Date | | As of December 31, | | | 2025 | | 2024 | | Principal amounts: | | | | | | | Second Lien Notes (1) | 17% | December 2026 | | $ | 86,194 | | | $ | 80,131 | | 2024 Term Loan (1) | 26% | September 2026 | | 46,075 | | | 48,500 | | | Acquisition-related promissory notes payable | 8% - 13% | June 2026 - April 2027 | | 28,337 | | | 22,289 | | | Mortgage loans | 6% - 10% | January 2027 - September 2030 | | 32,470 | | | 29,054 | | Total debt subject to scheduled repayments | | | | 193,076 | | | 179,974 | | Promissory notes payable to Sammartino (2) | 10% | September 2024 - September 2026 | | 21,500 | | | 21,500 | | Total debt | | | | 214,576 | | | 201,474 | | | Less: debt issuance costs and original issue discounts | | | | (8,742) | | | (15,267) | | Total debt, net | | | | $ | 205,834 | | | $ | 186,207 | | | Debt, net - current portion | | | | $ | 6,639 | | | $ | 2,758 | | | Debt, net - non-current portion | | | | $ | 199,195 | | | $ | 183,449 | |
(1)On March 27, 2026, the Company refinanced the Second Lien Notes and the 2024 Term Loan. Refer to Note 25 - Subsequent Events for more information. (2)This amount is related to the promissory notes issued to Sammartino Investments LLC (“Sammartino”) in connection with the acquisition of Nature's Remedy in September 2021. The Company currently has no obligation to pay the principal and interest. See further discussion of the Sammartino Matter in Note 22 - Commitments and Contingencies.
|
| Schedule of Future Contractual Debt Maturities |
As of December 31, 2025, aggregate future contractual maturities of the Company’s debt are as follows: | | | | | | | | | | | | | | | | | | | | | | 2026 | 2027 | 2028 | 2029 | 2030 | Total | Second Lien Notes(1) | $ | — | | $ | — | | $ | — | | $ | 86,194 | | $ | — | | $ | 86,194 | | | Acquisition-related promissory notes payable | 6,223 | | 22,114 | | — | | — | | — | | 28,337 | | Mortgage loans | 593 | | 9,413 | | 495 | | 539 | | 21,430 | | 32,470 | | 2024 Term loan(1) | — | | — | | — | | 46,075 | | — | | 46,075 | | Total debt subject to scheduled repayments | $ | 6,816 | | $ | 31,527 | | $ | 495 | | $ | 132,808 | | $ | 21,430 | | $ | 193,076 | |
|
| Schedule of Interest Expense |
Interest expense, net is comprised of the following: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | | | | | | | Interest and accretion - Second Lien Notes | $ | 13,368 | | | $ | 11,423 | | | $ | 10,106 | | | Interest and accretion - 2024 Term Loan | 12,077 | | | 4,653 | | | — | | Interest and accretion - Finance lease liabilities | 10,224 | | | 10,045 | | | 9,784 | | | Interest and accretion - Acquisition Facility | — | | | 4,844 | | | 9,466 | | Interest and accretion - Promissory notes | 3,554 | | | 4,421 | | | 6,173 | | Interest and accretion - Mortgage loans and other financing activities | 2,478 | | | 2,671 | | | 2,051 | | | Capitalized interest | (400) | | | (75) | | | (523) | | | Total interest expense | 41,301 | | | 37,982 | | | 37,057 | | | Interest income | (456) | | | (557) | | | (91) | | | Total interest expense, net | $ | 40,845 | | | $ | 37,425 | | | $ | 36,966 | |
|